FDA recalls Nipros diabetes insulin syringes

The FDA and Nipro Medical have issued a voluntary nationwide recall of all GlucoPro insulin syringes, which may have needles that detach from the syringe.

According to the agency, if the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into the syringe, or remain in the skin after injection. The recall includes all product codes and lot numbers with expiration dates before Nov. 1, 2011. The product was distributed across the U.S., including Puerto Rico.

Consumers who have GlucoPro Insulin Syringes should stop using them and return them to point of sale for reimbursement, according to the FDA notice.

The Miami-based company said this recall does not include the GlucoPro syringe specific for use with the Amigo Insulin pump. Also, GlucoPro said that no injuries have been reported to date.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.